Diane M Chappuis, MD | |
280 North Smith Avenue, Doctors Professional Building, Saint Paul, MN 55102-2459 | |
(651) 241-8295 | |
Not Available |
Full Name | Diane M Chappuis |
---|---|
Gender | Female |
Speciality | Physical Medicine And Rehabilitation |
Experience | 29 Years |
Location | 280 North Smith Avenue, Saint Paul, Minnesota |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1265492722 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 38991 (Minnesota) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Allina United Hospital | Saint paul, MN | Hospital |
Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
Healtheast St John's Hospital | Maplewood, MN | Hospital |
Mercy Hospital | Coon rapids, MN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Allina Health System | 4587573613 | 3071 |
News Archive
Investigators who studied a group of recreational marathon runners have established that strenuous exercise such as running a marathon can damage the heart muscle. Although they found the effect is temporary and reversible, they warn that these effects are more widespread in less fit distance runners and that recreational distance runners should prepare properly before marathons.
Minnesota HMOs recorded another year of healthy operating profits in 2011 despite agreeing to cap income on state Medicaid underwriting programs, a new analysis of state plans shows. Four HMOs returned $103 million in 2011 to the state after agreeing to limit their income on Medicaid underwriting business to 1 percent of their premiums.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
Canadian pharmacies that mail prescription drugs to U.S. patients have been backed into a no-win situation by the Canadian government and the provincial medical and pharmacy associations.
The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014.
› Verified 8 days ago
Entity Name | Allina Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Investigators who studied a group of recreational marathon runners have established that strenuous exercise such as running a marathon can damage the heart muscle. Although they found the effect is temporary and reversible, they warn that these effects are more widespread in less fit distance runners and that recreational distance runners should prepare properly before marathons.
Minnesota HMOs recorded another year of healthy operating profits in 2011 despite agreeing to cap income on state Medicaid underwriting programs, a new analysis of state plans shows. Four HMOs returned $103 million in 2011 to the state after agreeing to limit their income on Medicaid underwriting business to 1 percent of their premiums.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
Canadian pharmacies that mail prescription drugs to U.S. patients have been backed into a no-win situation by the Canadian government and the provincial medical and pharmacy associations.
The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Diane M Chappuis, MD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Diane M Chappuis, MD 280 North Smith Avenue, Doctors Professional Building, Saint Paul, MN 55102-2459 Ph: (651) 241-8295 |
News Archive
Investigators who studied a group of recreational marathon runners have established that strenuous exercise such as running a marathon can damage the heart muscle. Although they found the effect is temporary and reversible, they warn that these effects are more widespread in less fit distance runners and that recreational distance runners should prepare properly before marathons.
Minnesota HMOs recorded another year of healthy operating profits in 2011 despite agreeing to cap income on state Medicaid underwriting programs, a new analysis of state plans shows. Four HMOs returned $103 million in 2011 to the state after agreeing to limit their income on Medicaid underwriting business to 1 percent of their premiums.
Optimer Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for DIFICLIR (fidaxomicin) tablets for the treatment of adults suffering with a Clostridium difficile infection (CDI), also known as C. difficile-associated diarrhea.
Canadian pharmacies that mail prescription drugs to U.S. patients have been backed into a no-win situation by the Canadian government and the provincial medical and pharmacy associations.
The Burzynski Research Institute, Inc. (BRI) announced today that it will present data on two of the Company's clinical-stage product candidates, Antineoplaston A10 injections (Atengenal®) and Antineoplaston AS2-1 injections (Astugenal®), at the 16th International Symposium on Pediatric Neuro-Oncology held in Singapore from June 28, 2014 to July 2, 2014.
› Verified 8 days ago
Kristine Kay Spiewak, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 280 North Smith Avenue, Doctors Professional Building, Saint Paul, MN 55102 Phone: 651-241-8295 | |
Travis G O'brien, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 280 Smith Ave N Ste 220, Saint Paul, MN 55102 Phone: 651-241-8295 | |
Dr. Matthew Chase Severson, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 200 University Ave E, Saint Paul, MN 55101 Phone: 651-291-2848 Fax: 651-602-6885 | |
Eric Evan Kirksson, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1321 Payne Ave Unit 2, Saint Paul, MN 55130 Phone: 651-371-4880 Fax: 651-371-4881 | |
Marshall H Taniguchi, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 University Ave E, Saint Paul, MN 55101 Phone: 651-229-3819 Fax: 651-265-7443 | |
Linda E Krach, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 200 University Ave E, Saint Paul, MN 55101 Phone: 651-291-2848 Fax: 651-602-6885 | |
Bradley A Helms, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 295 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-495-6200 Fax: 952-883-9669 |